UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059162
Receipt number R000066146
Scientific Title A single-center prospective observational study evaluating the diagnostic yield of endoscopic ultrasound-guided tissue acquisition (EUS-TA) using BD CytoRich Red preservative fluid for pancreatic tumor
Date of disclosure of the study information 2025/09/22
Last modified on 2025/09/22 21:00:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the effectiveness of a novel preservative fluid (CytoRich Red) for diagnosing pancreatic tumor using endoscopic ultrasound

Acronym

Pancreatic tumor EUS Study (CytoRich)

Scientific Title

A single-center prospective observational study evaluating the diagnostic yield of endoscopic ultrasound-guided tissue acquisition (EUS-TA) using BD CytoRich Red preservative fluid for pancreatic tumor

Scientific Title:Acronym

CytoRich Red EUS-TA Pancreatic Tumor Study

Region

Japan


Condition

Condition

pancreatic tumor

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To prospectively evaluate the diagnostic yield of endoscopic ultrasound-guided tissue acquisition (EUS-TA) using BD CytoRich Red preservative fluid for pancreatic tumor.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Sensitivity, specificity, and accuracy of rapid on-site evaluation (ROSE)

Key secondary outcomes

Diagnostic yield of EUS-TA (Sensitivity, specificity, and accuracy based on histological and final cytological diagnoses)
Technical success rate of EUS-TA procedures
Incidence rate of adverse events (percentage of patients experiencing complications related to EUS-TA), details, and severity of adverse events
Proportion of samples successfully analyzed by next-generation sequencing (NGS) among specimens submitted for analysis
Proportion of tumor cells within collected samples
Detailed genomic alterations identified in successfully analyzed cases
Proportion of patients receiving targeted therapies matched to detected genomic alterations
Comparative evaluation of diagnostic yield and NGS success rate according to the type of needle used


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

150 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients undergoing endoscopic ultrasound-guided tissue acquisition (EUS-TA) for pancreatic tumors at our hospital between April 2025 and March 2028

Patients who provide written informed consent to participate in the study after receiving an adequate explanation and fully understanding the details

Key exclusion criteria

Patients who are medically ineligible for EUS-TA

Patients deemed inappropriate for participation in this study by the principal investigator or co-investigators

Target sample size

110


Research contact person

Name of lead principal investigator

1st name Hidenobu
Middle name
Last name Hara

Organization

Yokohama City Minato Red Cross Hospital

Division name

Gastroenterology

Zip code

2318682

Address

3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa, Japan

TEL

0456286100

Email

hidenobu1005_0406@yahoo.co.jp


Public contact

Name of contact person

1st name Hidenobu
Middle name
Last name Hara

Organization

Yokohama City Minato Red Cross Hospital

Division name

Gastroenterology

Zip code

2318682

Address

3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa, Japan

TEL

0456286100

Homepage URL


Email

hidenobu1005_0406@yahoo.co.jp


Sponsor or person

Institute

Yokohama City Minato Red Cross Hospital

Institute

Department

Personal name

Hidenobu Hara


Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City Minato Red Cross Hospital

Address

3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa, Japan

Tel

0456286100

Email

minato-kenkyu@yokohama.jrc.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 04 Month 04 Day

Date of IRB

2025 Year 04 Month 04 Day

Anticipated trial start date

2025 Year 04 Month 05 Day

Last follow-up date

2028 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Single-center prospective observational study


Management information

Registered date

2025 Year 09 Month 22 Day

Last modified on

2025 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066146